Rakovina Therapeutics Inc. | Finanzwire

Basculer en Français

9551	Companies
188461	Keywords
120293	Articles
100630	Press releases

Headlines Articles Press releases Rakovina Therapeutics Inc.

Home
Companies
Rakovina Therapeutics Inc.

BRIEF

published on 04/02/2025 at 15:36, 8 months 16 days ago

Rakovina Therapeutics Receives Buy Rating from First Berlin Equity Research

Artificial Intelligence DNA Damage Response Rakovina Therapeutics PARP And ATR Biotech Investment
PRESS RELEASE

published on 04/02/2025 at 15:31, 8 months 16 days ago

Original-Research: Rakovina Therapeutics Inc. (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research initiates coverage on Rakovina Therapeutics Inc. with a Buy recommendation and CAD 0.40 target price. Rakovina focuses on DNA Damage Response pathways in developing next-gen cancer treatments

First Berlin Equity Research Buy Recommendation Rakovina Therapeutics Inc. DNA Damage Response Pathways CAD 0.40 Target Price

Accesswire

Published on 12/18/2025 at 18:00, 29 minutes ago

PPX Mining Announces 2025 AGM Results
Published on 12/18/2025 at 15:00, 3 hours 29 minutes ago

Vox Royalty Acquires Feasibilty-Stage Stockman Copper-Gold Royalty in Australia
Published on 12/18/2025 at 14:31, 3 hours 58 minutes ago

Worksport Reports Highest Monthly Revenue in Company History
Published on 12/18/2025 at 14:00, 4 hours 29 minutes ago

Route1 Announces Provisional Patent Application
Published on 12/18/2025 at 14:00, 4 hours 29 minutes ago

LQR House Announces $6.52 Million Registered Direct Offering

View all ACCESSWIRE

EQS Group

Published on 12/18/2025 at 18:01, 27 minutes ago

POS-Transaction in Own Shares
Published on 12/18/2025 at 18:00, 29 minutes ago

Wicomico County Selects Waga Energy to Upgrade Landfill Gas to RNG in Maryland
Published on 12/18/2025 at 17:45, 44 minutes ago

ENOGIA: ENOGIA selected to supply South Korea’s first fully privately financed waste-heat-to-power project on a fuel cell plant
Published on 12/18/2025 at 17:40, 49 minutes ago

LIGHTON: Information concerning the total number of voting rights and shares in the share capital as of 30 november 2025.
Published on 12/18/2025 at 17:40, 49 minutes ago

VALBIOTIS SA: Valbiotis recognized by the 2025 Top Santé Award for Valbiotis Plus® Serenity, an innovative solution for emotional balance

Les Echos

Published on 12/18/2025 at 17:45, 44 minutes ago

Cie du Bois Sauvage : Cancellation of own shares
Published on 12/18/2025 at 16:31, 1 hour 58 minutes ago

In Brazil, ENGIE Fully Commissions Serra do Assuruá, Its Largest Wind Complex Worldwide
Published on 12/17/2025 at 20:39, 21 hours 50 minutes ago

Aeroports de Paris SA | 2026 Airport charges in Paris
Published on 12/17/2025 at 19:30, 22 hours 59 minutes ago

Change in the composition of the Board
Published on 12/17/2025 at 18:00, 1 day ago

Outstanding Shares and Voting Rights Statement at 30 November 2025

View all LES ECHOS COMFI WIRE